Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York

Tuesday, November 4, 2008 General News J E 4
THOUSAND OAKS, Calif., Nov. 3 Amgen(Nasdaq: AMGN) today announced that it will hold its Business Review Meetingon Friday, Nov. 7, 2008 at the Millennium Broadway Hotel, 145 West 44thStreet, New York City, beginning at 8 a.m. Eastern Time. Participating in themeeting will be Kevin Sharer, chairman and CEO, Roger M. Perlmutter, M.D.,Ph.D., executive vice president, Research and Development, George Morrow,executive vice president, Global Commercial Operations, Robert Bradway,executive vice president and CFO, and other members of Amgen's seniormanagement team.

Live video of the meeting will be simultaneously broadcast over theInternet and will be available to members of the news media, investors and thegeneral public.

The webcast of the conference, as with other selected presentationsregarding developments in Amgen's business given by management at certaininvestor and medical conferences, can be found on Amgen's Web site,, under Investors. Information regarding presentationtimes, webcast availability, and webcast links are noted on Amgen's InvestorRelations Events Calendar. The webcast will be archived and available forreplay 72 hours after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative humantherapeutics. A biotechnology pioneer since 1980, Amgen was one of the firstcompanies to realize the new science's promise by bringing safe and effectivemedicines from lab, to manufacturing plant, to patient. Amgen therapeuticshave changed the practice of medicine, helping millions of people around theworld in the fight against cancer, kidney disease, rheumatoid arthritis, andother serious illnesses. With a deep and broad pipeline of potential newmedicines, Amgen remains committed to advancing science to dramaticallyimprove people's lives. To learn more about our pioneering science and ourvital medicines, visit Amgen, Thousand Oaks David Polk, 805-447-4613 (media) Arvind Sood, 805-447-1060 (investors) (Logo:



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Listing Review initiated by the Toronto Stock Exch...
Vion Reports 2008 Third Quarter and Nine-Month Res...